Bortezomib, 3.5 mg/vial, Single-Dose Vial, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited, Visakhapatnam - 530 046, India, NDC 43598-865-60
Published March 2, 2022 · Recall initiated: January 19, 2022
Summary
FDA records drug Class III recall D-0577-2022, published March 2, 2022 and initiated January 19, 2022. Recalling firm: Dr. Reddy's Laboratories, Inc.; Status: Terminated; Reported quantity: 2,980 vials; Lot: Lot # H210233, Exp 3/1/2023. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed stability specifications
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Dr. Reddy's Laboratories, Inc.
- Distributor
- USA Nationwide
- Lot
- Lot # H210233, Exp 3/1/2023
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAVarenicline Tablets, 1mg, 56 Tablets, Rx only, Distributor: Dr. Reddy's Laboratories Inc., Princeton, NJDecember 17, 2025
- FDASuccinylcholine Chloride Injection, USP, 200 mg/10 mL (20 mg/mL), 25 x 10 mL Multiple-Dose Vials, ForOctober 15, 2025
- FDAOmeprazole Delayed-release Capsules, USP, 20mg, 1000-count bottle, Rx Only, Manufactured by: Dr. Reddy'sJuly 23, 2025
- FDALevetiracetam 0.75% in Sodium Chloride Injection 1,000 mg/100 mL (10 mg/mL), 1 x 100mL, Rx Only, ManufacturedApril 23, 2025
- FDAAzacitidine, 100mg/vial, One Single-dose Vial, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited,March 2, 2022
- FDAAcetaminophen Oral Suspension Grape Flavor, 160 mg per 5 mL, 16 fl oz (473 mL) per bottle, Distributed byMarch 2, 2022
Questions about this recall
Was Bortezomib, 3.5 mg/vial, Single-Dose Vial, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited, Visakhapatnam - 530 046, India, NDC 43598-865-60 recalled?
Yes. FDA published recall D-0577-2022 on March 2, 2022. Reported hazard: Failed stability specifications
What should I do if I have this product?
Voluntary: Firm initiated · Letter